Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
S1PR1 Biologics Sequence Review Report 2026: Sphingosine 1-phosphate receptor 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
S1PR1 Biologics Sequence Review Report 2026: Sphingosine 1-phosphate receptor 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of S1PR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PDGFD Biologics Sequence Review Report 2026: Platelet-derived growth factor D Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PDGFD Biologics Sequence Review Report 2026: Platelet-derived growth factor D Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFD protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PDGFC Biologics Sequence Review Report 2026: Platelet-derived growth factor C Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PDGFC Biologics Sequence Review Report 2026: Platelet-derived growth factor C Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PDGFB Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit B Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PDGFB Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit B Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PDGFA Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit A Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PDGFA Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit A Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
P2RY8 Biologics Sequence Review Report 2026: S-geranylgeranyl-glutathione receptor P2RY8 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
P2RY8 Biologics Sequence Review Report 2026: S-geranylgeranyl-glutathione receptor P2RY8 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of P2RY8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP28 Biologics Sequence Review Report 2026: Matrix metalloproteinase-28 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP28 Biologics Sequence Review Report 2026: Matrix metalloproteinase-28 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP27 Biologics Sequence Review Report 2026: Matrix metalloproteinase-27 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP27 Biologics Sequence Review Report 2026: Matrix metalloproteinase-27 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP23B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →